Mechanism of aromatic nitro group reduction in the soluble fraction of human placenta.
D062365:Aminobenzoates / Q000378:metabolism; D000645:Ammonium Sulfate; D002248:Carbon Monoxide / Q000494:pharmacology; D003956:Dialysis; D005260:Female; D005486:Flavin Mononucleotide / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008706:Methemoglobin / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D009574:Nitro Compounds / Q000378:metabolism; D009578:Nitrobenzenes / Q000378:metabolism; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010100:Oxygen / Q000494:pharmacology; D010920:Placenta / Q000201:enzymology / Q000378:metabolism*; D011247:Pregnancy; D011506:Proteins / Q000032:analysis; D014462:Ultrafiltration
D062365:Aminobenzoates; D009574:Nitro Compounds; D009578:Nitrobenzenes; D011506:Proteins; D009249:NADP; D005486:Flavin Mononucleotide; D002248:Carbon Monoxide; D008706:Methemoglobin; D010088:Oxidoreductases; D010100:Oxygen; D000645:Ammonium Sulfate